We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice for medical professionals to use when assessing drivers with cardiovascular disorders.
How to spot paramyxovirus infection in pigeons, what to do if you suspect it and measures to prevent its spread.
Advice and guidance on the health needs of migrant patients from Barbados for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Argentina for healthcare practitioners.
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
Gastrointestinal diseases can be notified using this form.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Brazil for healthcare practitioners.
Marketing standards for poultry meat producers, manufacturers, retailers and distributors.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Guidance on the main diseases that affect cattle, disease prevention and legal controls in place to protect cattle health.
The characteristics, diagnosis, epidemiology of hantaviruses.
Advice and guidance on the health needs of migrant patients from Egypt for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Costa Rica for healthcare practitioners.
The characteristics, diagnosis, management, surveillance and epidemiology of Staphylococcus aureus.
The characteristics, diagnosis, management, surveillance and epidemiology Enterococcus species and Glycopeptide Resistant Enterococci (GRE).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.